ATOS vs. FCX
Compare and contrast key facts about Atossa Therapeutics, Inc. (ATOS) and Freeport-McMoRan Inc. (FCX).
Performance
ATOS vs. FCX - Performance Comparison
Loading graphics...
ATOS vs. FCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ATOS Atossa Therapeutics, Inc. | -40.56% | -37.51% | 7.28% | 66.51% | -66.97% | 68.42% | -39.49% | 53.92% | -67.31% | -81.56% |
FCX Freeport-McMoRan Inc. | 16.02% | 35.41% | -9.41% | 13.69% | -7.91% | 61.41% | 99.06% | 29.59% | -45.11% | 43.75% |
Fundamentals
ATOS:
-$3.50
FCX:
$1.91
ATOS:
$0.00
FCX:
$25.74B
ATOS:
-$16.00K
FCX:
$6.95B
ATOS:
-$32.28M
FCX:
$8.76B
Returns By Period
In the year-to-date period, ATOS achieves a -40.56% return, which is significantly lower than FCX's 16.02% return. Over the past 10 years, ATOS has underperformed FCX with an annualized return of -40.00%, while FCX has yielded a comparatively higher 20.64% annualized return.
ATOS
- 1D
- 11.68%
- 1M
- 18.74%
- YTD
- -40.56%
- 6M
- -59.55%
- 1Y
- -47.89%
- 3Y*
- -21.50%
- 5Y*
- -30.48%
- 10Y*
- -40.00%
FCX
- 1D
- 7.56%
- 1M
- -13.66%
- YTD
- 16.02%
- 6M
- 50.78%
- 1Y
- 57.42%
- 3Y*
- 14.42%
- 5Y*
- 13.14%
- 10Y*
- 20.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATOS vs. FCX — Risk / Return Rank
ATOS
FCX
ATOS vs. FCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atossa Therapeutics, Inc. (ATOS) and Freeport-McMoRan Inc. (FCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ATOS | FCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.61 | 1.14 | -1.75 |
Sortino ratioReturn per unit of downside risk | -0.56 | 1.58 | -2.14 |
Omega ratioGain probability vs. loss probability | 0.93 | 1.23 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | -0.64 | 2.21 | -2.85 |
Martin ratioReturn relative to average drawdown | -1.32 | 5.81 | -7.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ATOS | FCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.61 | 1.14 | -1.75 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.39 | 0.30 | -0.69 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.26 | 0.42 | -0.68 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.30 | 0.15 | -0.45 |
Correlation
The correlation between ATOS and FCX is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ATOS vs. FCX - Dividend Comparison
ATOS has not paid dividends to shareholders, while FCX's dividend yield for the trailing twelve months is around 1.02%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATOS Atossa Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FCX Freeport-McMoRan Inc. | 1.02% | 1.18% | 1.58% | 1.41% | 0.99% | 0.54% | 0.19% | 1.52% | 1.45% | 0.00% | 0.00% | 8.46% |
Drawdowns
ATOS vs. FCX - Drawdown Comparison
The maximum ATOS drawdown since its inception was -99.99%, which is greater than FCX's maximum drawdown of -92.52%. Use the drawdown chart below to compare losses from any high point for ATOS and FCX.
Loading graphics...
Drawdown Indicators
| ATOS | FCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -92.52% | -7.47% |
Max Drawdown (1Y)Largest decline over 1 year | -77.74% | -24.90% | -52.84% |
Max Drawdown (5Y)Largest decline over 5 years | -96.95% | -51.47% | -45.48% |
Max Drawdown (10Y)Largest decline over 10 years | -99.63% | -72.59% | -27.04% |
Current DrawdownCurrent decline from peak | -99.98% | -14.59% | -85.39% |
Average DrawdownAverage peak-to-trough decline | -93.51% | -39.82% | -53.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.68% | 9.48% | +28.20% |
Volatility
ATOS vs. FCX - Volatility Comparison
Atossa Therapeutics, Inc. (ATOS) has a higher volatility of 25.78% compared to Freeport-McMoRan Inc. (FCX) at 16.77%. This indicates that ATOS's price experiences larger fluctuations and is considered to be riskier than FCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ATOS | FCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.78% | 16.77% | +9.01% |
Volatility (6M)Calculated over the trailing 6-month period | 67.40% | 31.53% | +35.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.69% | 50.77% | +27.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.39% | 44.70% | +33.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 155.92% | 49.31% | +106.61% |
Financials
ATOS vs. FCX - Financials Comparison
This section allows you to compare key financial metrics between Atossa Therapeutics, Inc. and Freeport-McMoRan Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities